Results 111 to 120 of about 43,408 (239)
Molecular structure provides a complementary perspective on drug‐induced liver injury. Integrating 801 drugs across five DILI endpoints, our interpretable AI framework reveals endpoint‐dependent structural contributions and links predictive classification with molecular‐level interpretation, highlighting the complex interplay between clinical ...
Priya Kumari, Kunal Roy, Madhulika Gupta
wiley +1 more source
Diagnostic Options in Graves' or Non‐Graves' Thyrotoxicosis: A Review for Clinical Practice
ABSTRACT Objective Distinguishing Graves' disease (GD) from the other causes of thyrotoxicosis is essential for appropriate management. The clinical phenotype of GD has evolved over time and is currently more heterogenous and milder than in the past. Consequently, the differential diagnosis of thyrotoxicosis is often challenging.
Lorenzo Scappaticcio +7 more
wiley +1 more source
Mechanisms of hepatocellular toxicity associated with dronedarone--a comparison to amiodarone
Dronedarone is a new antiarrhythmic drug with an amiodarone-like benzofuran structure. Shortly after its introduction, dronedarone became implicated in causing severe liver injury. Amiodarone is a well-known mitochondrial toxicant.
Blum, Kim +6 more
core +1 more source
Acute Liver and Renal Failure: A Rare Adverse Effect Exclusive to Intravenous form of Amiodarone
Amiodarone is an antiarrhythmic drug which is highly effective against a wide spectrum of ventricular tachyarrhythmias making it irreplaceable in certain group of patients.
Robin Paudel +4 more
doaj +1 more source
Timing of Cardiac Contractility Modulation Therapy Implementation
In this retrospective registry analysis, cardiac contractility modulation (CCM) improved functional status and left ventricular ejection fraction whether implanted early or later. Implantation within 12 months after CCM‐eligible heart failure diagnosis might be associated with better survival, greater ejection‐fraction improvement, and fewer heart ...
Goekhan Yuecel +12 more
wiley +1 more source
Background Amiodarone is commonly used during therapeutic hypothermia (TH) following cardiac arrest due to ventricular arrhythmias. However, electrophysiological changes and proarrhythmic risk after amiodarone treatment have not yet been explored in TH ...
Chin-Yu Lin +13 more
doaj
ABSTRACT Background and Aims Vitiligo shares inflammatory and metabolic pathways with cardiovascular and hepatic steatosis. Carotid intima–media thickness (IMT) is an established marker of early subclinical atherosclerosis, whereas non‐alcoholic fatty liver disease (NAFLD) reflects hepatic involvement in chronic inflammatory and metabolic dysregulation.
Mehrdad Mozafar +8 more
wiley +1 more source
Subclinical Hypothyroidism after a Three-Month Course of Low-Dose Amiodarone. [PDF]
This case report describes a 64-year-old male who developed subclinical hypothyroidism after three months of low-dose amiodarone (100 mg/day). Routine monitoring showed a TSH increase to 44.40 mU/L with normal FT4 and FT3 levels.
Aidana Butabayeva +11 more
core +2 more sources
Central illustration depicting trends in demographics and differences in Ventricular Arrhythmias with Cardiomyopathy‐related Mortality among adults in the United States from 1999 to 2024. ABSTRACT Background Ventricular Arrhythmias (VA) associated with Cardiomyopathy (CM) continues to be the major cause of death.
Nosheen Pervaiz +8 more
wiley +1 more source
Summary •Amiodarone optic neuropathy o Amiodarone is an anti-arrhythmic used by cardiology -Amiodarone produces a toxic optic neuropathy that looks similar to non-arteritic anterior ischemic optic neuropathy (NAION) o Differentiating features between ...
Andrew G. Lee, MD; Jason Zehden
core

